Geneos Wealth Management’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Geneos Wealth Management’s Portfolio TCAF Stock Details TCAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Buy	4,938 +1,783	+57%	+$70.5K	﹤0.01%	987
2026 Q1	$112K	Buy	3,155 +850	+37%	+$31.8K	﹤0.01%	1138
2025 Q4	$88.1K	Buy	2,305 +310	+16%	+$11.9K	﹤0.01%	1186
2025 Q3	$75.2K	Buy	1,995 +400	+25%	+$14.6K	﹤0.01%	1221
2025 Q2	$56.3K	Buy	1,595 +1,130	+243%	+$37.1K	﹤0.01%	1506
2025 Q1	$15K	Buy	+465	New	+$15.6K	﹤0.01%	2076

Other funds holding TCAF

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Geneos Wealth Management's TCAF Position: Q2 2026 in Review

Geneos Wealth Management increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 57% in Q2 2026, buying an estimated $70.5K and bringing the position to 4,938 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Geneos Wealth Management first reported a position in TCAF in Q1 2025 and has held it in 6 quarters since. 359 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

Geneos Wealth Management held 4,938 shares of T. Rowe Price Capital Appreciation Equity ETF worth $203K as of Q2 2026.
Geneos Wealth Management bought 1,783 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $70.5K.
T. Rowe Price Capital Appreciation Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #987 holding.
Geneos Wealth Management first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q1 2025 and has held it in 6 quarters since.
359 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.